StockData
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

PRO DEX INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 3, 2026
$57.70−0.56 (-0.96%)

Close on Oct 19, 2026

Market cap
$193.98M
P/E (TTM)
14.0
Dividend yield
–

Earnings

Next report expected Oct 29, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2026
Ended Jun 30, 2026
Sep 3, 2026After market close$20.40M$0.87–
Q3 FY2026
Ended Mar 31, 2026
Apr 30, 2026After market close$19.90M$1.20–
Q2 FY2026
Ended Dec 31, 2025
Jan 29, 2026After market close$18.70M$0.66–
Q1 FY2026
Ended Sep 30, 2025
Oct 30, 2025After market close$18.50M$1.40–
Q4 FY2025
Ended Jun 30, 2025
Sep 4, 2025After market close$17.50M$0.36–
Q3 FY2025
Ended Mar 31, 2025
May 1, 2025After market close$17.40M$0.98–
Q2 FY2025
Ended Dec 31, 2024
Jan 30, 2025After market close$16.80M$0.61–
Q1 FY2025
Ended Sep 30, 2024
Oct 31, 2024After market close$14.90M$0.75–
Q4 FY2024
Ended Jun 30, 2024
Sep 5, 2024After market close$15.00M$0.46–
Q3 FY2024
Ended Mar 31, 2024
May 2, 2024After market close–––
Q2 FY2024
Ended Dec 31, 2023
Feb 8, 2024After market close–––

Press releases

Announcements Pro Dex filed with the SEC